APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI-Based Medical Transcription

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global AI-Based Medical Transcription Market Analysis and Forecast 2026-2032

16 April 2026237 pages

Choose your research edition.

Industry ResearchAI-Based Medical Transcription Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal AI-Based Medical Transcription Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal AI-Based Medical Transcription Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI-Based Medical Transcription Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal AI-Based Medical Transcription Market Analysis and Forecast 2026-2032237 pages · $4,950 USD

Market perspective

The global AI-Based Medical Transcription market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for AI-Based Medical Transcription is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for AI-Based Medical Transcription is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for AI-Based Medical Transcription is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for AI-Based Medical Transcription is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of AI-Based Medical Transcription include Nuance Communications, Abridge, DeepScribe, Heidi Health, InfraWare, Rev, Suki AI, Otter.ai and Verbit.ai, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for AI-Based Medical Transcription, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of AI-Based Medical Transcription, also provides the revenue of main regions and countries. Of the upcoming market potential for AI-Based Medical Transcription, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the AI-Based Medical Transcription revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global AI-Based Medical Transcription market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for AI-Based Medical Transcription revenue, projected growth trends, production technology, application and end-user industry.

AI-Based Medical Transcription Segment by Company

Nuance Communications

Abridge

DeepScribe

Heidi Health

InfraWare

Rev

Suki AI

Otter.ai

Verbit.ai

Freed

AI-Based Medical Transcription Segment by Type

Software

Services

AI-Based Medical Transcription Segment by Application

Hospitals

Clinics

Diagnostic Centers

Others

AI-Based Medical Transcription Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI-Based Medical Transcription market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI-Based Medical Transcription and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI-Based Medical Transcription.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of AI-Based Medical Transcription in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of AI-Based Medical Transcription company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI-Based Medical Transcription revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI-Based Medical Transcription Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Software Major Player Table 3. Services Major Player Table 4. Global AI-Based Medical Transcription Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals Major Player Table 6. Clinics Major Player Table 7. Diagnostic Centers Major Player Table 8. Others Major Player Table 9. AI-Based Medical Transcription Industry Trends Table 10. AI-Based Medical Transcription Industry Drivers Table 11. AI-Based Medical Transcription Industry Opportunities and Challenges Table 12. AI-Based Medical Transcription Industry Restraints Table 13. Global AI-Based Medical Transcription Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global AI-Based Medical Transcription Market Size by Region (2021-2026) & (US$ Million) Table 15. Global AI-Based Medical Transcription Market Share by Region (2021-2026) Table 16. Global AI-Based Medical Transcription Market Size by Region (2027-2032) & (US$ Million) Table 17. Global AI-Based Medical Transcription Market Share by Region (2027-2032) Table 18. Global AI-Based Medical Transcription Revenue by Players (US$ Million) & (2021-2026) Table 19. Global AI-Based Medical Transcription Revenue Market Share by Players (2021-2026) Table 20. Global AI-Based Medical Transcription Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global AI-Based Medical Transcription Key Players Headquarters & Area Served Table 22. Global AI-Based Medical Transcription Players, Product Type & Application Table 23. Global AI-Based Medical Transcription Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global AI-Based Medical Transcription by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global AI-Based Medical Transcription Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global AI-Based Medical Transcription Revenue by Type (2021-2026) & (US$ Million) Table 28. Global AI-Based Medical Transcription Revenue by Type (2027-2032) & (US$ Million) Table 29. Global AI-Based Medical Transcription Revenue Market Share by Type (2021-2026) Table 30. Global AI-Based Medical Transcription Revenue Market Share by Type (2027-2032) Table 31. Global AI-Based Medical Transcription Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global AI-Based Medical Transcription Revenue by Application (2021-2026) & (US$ Million) Table 33. Global AI-Based Medical Transcription Revenue by Application (2027-2032) & (US$ Million) Table 34. Global AI-Based Medical Transcription Revenue Market Share by Application (2021-2026) Table 35. Global AI-Based Medical Transcription Revenue Market Share by Application (2027-2032) Table 36. Nuance Communications Company Information Table 37. Nuance Communications Business Overview Table 38. Nuance Communications AI-Based Medical Transcription Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Nuance Communications AI-Based Medical Transcription Product Portfolio Table 40. Nuance Communications Recent Development Table 41. Abridge Company Information Table 42. Abridge Business Overview Table 43. Abridge AI-Based Medical Transcription Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Abridge AI-Based Medical Transcription Product Portfolio Table 45. Abridge Recent Development Table 46. DeepScribe Company Information Table 47. DeepScribe Business Overview Table 48. DeepScribe AI-Based Medical Transcription Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. DeepScribe AI-Based Medical Transcription Product Portfolio Table 50. DeepScribe Recent Development Table 51. Heidi Health Company Information Table 52. Heidi Health Business Overview Table 53. Heidi Health AI-Based Medical Transcription Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Heidi Health AI-Based Medical Transcription Product Portfolio Table 55. Heidi Health Recent Development Table 56. InfraWare Company Information Table 57. InfraWare Business Overview Table 58. InfraWare AI-Based Medical Transcription Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. InfraWare AI-Based Medical Transcription Product Portfolio Table 60. InfraWare Recent Development Table 61. Rev Company Information Table 62. Rev Business Overview Table 63. Rev AI-Based Medical Transcription Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Rev AI-Based Medical Transcription Product Portfolio Table 65. Rev Recent Development Table 66. Suki AI Company Information Table 67. Suki AI Business Overview Table 68. Suki AI AI-Based Medical Transcription Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Suki AI AI-Based Medical Transcription Product Portfolio Table 70. Suki AI Recent Development Table 71. Otter.ai Company Information Table 72. Otter.ai Business Overview Table 73. Otter.ai AI-Based Medical Transcription Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Otter.ai AI-Based Medical Transcription Product Portfolio Table 75. Otter.ai Recent Development Table 76. Verbit.ai Company Information Table 77. Verbit.ai Business Overview Table 78. Verbit.ai AI-Based Medical Transcription Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Verbit.ai AI-Based Medical Transcription Product Portfolio Table 80. Verbit.ai Recent Development Table 81. Freed Company Information Table 82. Freed Business Overview Table 83. Freed AI-Based Medical Transcription Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Freed AI-Based Medical Transcription Product Portfolio Table 85. Freed Recent Development Table 86. North America AI-Based Medical Transcription Revenue by Type (2021-2026) & (US$ Million) Table 87. North America AI-Based Medical Transcription Revenue by Type (2027-2032) & (US$ Million) Table 88. North America AI-Based Medical Transcription Revenue by Application (2021-2026) & (US$ Million) Table 89. North America AI-Based Medical Transcription Revenue by Application (2027-2032) & (US$ Million) Table 90. North America AI-Based Medical Transcription Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America AI-Based Medical Transcription Revenue by Country (2021-2026) & (US$ Million) Table 92. North America AI-Based Medical Transcription Revenue by Country (US$ Million) & (2027-2032) Table 93. Europe AI-Based Medical Transcription Revenue by Type (2021-2026) & (US$ Million) Table 94. Europe AI-Based Medical Transcription Revenue by Type (2027-2032) & (US$ Million) Table 95. Europe AI-Based Medical Transcription Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe AI-Based Medical Transcription Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe AI-Based Medical Transcription Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe AI-Based Medical Transcription Revenue by Country (2021-2026) & (US$ Million) Table 99. Europe AI-Based Medical Transcription Revenue by Country (US$ Million) & (2027-2032) Table 100. China AI-Based Medical Transcription Revenue by Type (2021-2026) & (US$ Million) Table 101. China AI-Based Medical Transcription Revenue by Type (2027-2032) & (US$ Million) Table 102. China AI-Based Medical Transcription Revenue by Application (2021-2026) & (US$ Million) Table 103. China AI-Based Medical Transcription Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia AI-Based Medical Transcription Revenue by Type (2021-2026) & (US$ Million) Table 105. Asia AI-Based Medical Transcription Revenue by Type (2027-2032) & (US$ Million) Table 106. Asia AI-Based Medical Transcription Revenue by Application (2021-2026) & (US$ Million) Table 107. Asia AI-Based Medical Transcription Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia AI-Based Medical Transcription Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia AI-Based Medical Transcription Revenue by Region (US$ Million) & (2021-2026) Table 110. Asia AI-Based Medical Transcription Revenue by Region (US$ Million) & (2027-2032) Table 111. SAMEA AI-Based Medical Transcription Revenue by Type (2021-2026) & (US$ Million) Table 112. SAMEA AI-Based Medical Transcription Revenue by Type (2027-2032) & (US$ Million) Table 113. SAMEA AI-Based Medical Transcription Revenue by Application (2021-2026) & (US$ Million) Table 114. SAMEA AI-Based Medical Transcription Revenue by Application (2027-2032) & (US$ Million) Table 115. SAMEA AI-Based Medical Transcription Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. SAMEA AI-Based Medical Transcription Revenue by Country (2021-2026) & (US$ Million) Table 117. SAMEA AI-Based Medical Transcription Revenue by Country (US$ Million) & (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. AI-Based Medical Transcription Image Figure 2. Global AI-Based Medical Transcription Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI-Based Medical Transcription Market Size Share 2021 VS 2025 VS 2032 Figure 4. Software Image Figure 5. Services Image Figure 6. Global AI-Based Medical Transcription Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global AI-Based Medical Transcription Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospitals Image Figure 9. Clinics Image Figure 10. Diagnostic Centers Image Figure 11. Others Image Figure 12. Global AI-Based Medical Transcription Market Size (US$ Million) & (2021-2032) Figure 13. Global AI-Based Medical Transcription Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global AI-Based Medical Transcription Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global AI-Based Medical Transcription Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global AI-Based Medical Transcription Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global AI-Based Medical Transcription Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global AI-Based Medical Transcription Revenue Market Share by Type (2021-2032) Figure 20. Global AI-Based Medical Transcription Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global AI-Based Medical Transcription Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global AI-Based Medical Transcription Revenue Market Share by Application (2021-2032) Figure 23. North America AI-Based Medical Transcription Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America AI-Based Medical Transcription Revenue Share by Type (2021-2032) Figure 25. North America AI-Based Medical Transcription Revenue Share by Application (2021-2032) Figure 26. North America AI-Based Medical Transcription Revenue Share by Country (2021-2032) Figure 27. United States AI-Based Medical Transcription Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada AI-Based Medical Transcription Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico AI-Based Medical Transcription Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe AI-Based Medical Transcription Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe AI-Based Medical Transcription Revenue Share by Type (2021-2032) Figure 32. Europe AI-Based Medical Transcription Revenue Share by Application (2021-2032) Figure 33. Europe AI-Based Medical Transcription Revenue Share by Country (2021-2032) Figure 34. Germany AI-Based Medical Transcription Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France AI-Based Medical Transcription Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. AI-Based Medical Transcription Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy AI-Based Medical Transcription Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain AI-Based Medical Transcription Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia AI-Based Medical Transcription Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands AI-Based Medical Transcription Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries AI-Based Medical Transcription Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China AI-Based Medical Transcription Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China AI-Based Medical Transcription Revenue Share by Type (2021-2032) Figure 44. China AI-Based Medical Transcription Revenue Share by Application (2021-2032) Figure 45. Asia AI-Based Medical Transcription Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia AI-Based Medical Transcription Revenue Share by Type (2021-2032) Figure 47. Asia AI-Based Medical Transcription Revenue Share by Application (2021-2032) Figure 48. Asia AI-Based Medical Transcription Revenue Share by Region (2021-2032) Figure 49. Japan AI-Based Medical Transcription Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea AI-Based Medical Transcription Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India AI-Based Medical Transcription Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia AI-Based Medical Transcription Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan AI-Based Medical Transcription Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia AI-Based Medical Transcription Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA AI-Based Medical Transcription Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA AI-Based Medical Transcription Revenue Share by Type (2021-2032) Figure 57. SAMEA AI-Based Medical Transcription Revenue Share by Application (2021-2032) Figure 58. SAMEA AI-Based Medical Transcription Revenue Share by Country (2021-2032) Figure 59. Brazil AI-Based Medical Transcription Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina AI-Based Medical Transcription Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile AI-Based Medical Transcription Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia AI-Based Medical Transcription Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru AI-Based Medical Transcription Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia AI-Based Medical Transcription Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel AI-Based Medical Transcription Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE AI-Based Medical Transcription Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey AI-Based Medical Transcription Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran AI-Based Medical Transcription Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt AI-Based Medical Transcription Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Software
  • Services
Applications
  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Others
Companies covered
  • Nuance Communications
  • Abridge
  • DeepScribe
  • Heidi Health
  • InfraWare
  • Rev
  • Suki AI
  • Otter.ai
  • Verbit.ai
  • Freed

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 AI-Based Medical Transcription Market by Type
  3. 1.2.1 Global AI-Based Medical Transcription Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Software
  5. 1.2.3 Services
  6. 1.3 AI-Based Medical Transcription Market by Application
  7. 1.3.1 Global AI-Based Medical Transcription Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals
  9. 1.3.3 Clinics
  10. 1.3.4 Diagnostic Centers
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 AI-Based Medical Transcription Market Dynamics
  1. 2.1 AI-Based Medical Transcription Industry Trends
  2. 2.2 AI-Based Medical Transcription Industry Drivers
  3. 2.3 AI-Based Medical Transcription Industry Opportunities and Challenges
  4. 2.4 AI-Based Medical Transcription Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global AI-Based Medical Transcription Market Perspective (2021-2032)
  2. 3.2 Global AI-Based Medical Transcription Growth Trends by Region
  3. 3.2.1 Global AI-Based Medical Transcription Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global AI-Based Medical Transcription Market Size by Region (2021-2026)
  5. 3.2.3 Global AI-Based Medical Transcription Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global AI-Based Medical Transcription Revenue by Players
  2. 4.1.1 Global AI-Based Medical Transcription Revenue by Players (2021-2026)
  3. 4.1.2 Global AI-Based Medical Transcription Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global AI-Based Medical Transcription Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global AI-Based Medical Transcription Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global AI-Based Medical Transcription Key Players Headquarters & Area Served
  7. 4.4 Global AI-Based Medical Transcription Players, Product Type & Application
  8. 4.5 Global AI-Based Medical Transcription Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global AI-Based Medical Transcription Market CR5 and HHI
  11. 4.6.3 2025 AI-Based Medical Transcription Tier 1, Tier 2, and Tier 3
5 AI-Based Medical Transcription Market Size by Type
  1. 5.1 Global AI-Based Medical Transcription Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global AI-Based Medical Transcription Revenue by Type (2021-2032)
  3. 5.3 Global AI-Based Medical Transcription Revenue Market Share by Type (2021-2032)
6 AI-Based Medical Transcription Market Size by Application
  1. 6.1 Global AI-Based Medical Transcription Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global AI-Based Medical Transcription Revenue by Application (2021-2032)
  3. 6.3 Global AI-Based Medical Transcription Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Nuance Communications
  2. 7.1.1 Nuance Communications Company Information
  3. 7.1.2 Nuance Communications Business Overview
  4. 7.1.3 Nuance Communications AI-Based Medical Transcription Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Nuance Communications AI-Based Medical Transcription Product Portfolio
  6. 7.1.5 Nuance Communications Recent Developments
  7. 7.2 Abridge
  8. 7.2.1 Abridge Company Information
  9. 7.2.2 Abridge Business Overview
  10. 7.2.3 Abridge AI-Based Medical Transcription Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Abridge AI-Based Medical Transcription Product Portfolio
  12. 7.2.5 Abridge Recent Developments
  13. 7.3 DeepScribe
  14. 7.3.1 DeepScribe Company Information
  15. 7.3.2 DeepScribe Business Overview
  16. 7.3.3 DeepScribe AI-Based Medical Transcription Revenue and Gross Margin (2021-2026)
  17. 7.3.4 DeepScribe AI-Based Medical Transcription Product Portfolio
  18. 7.3.5 DeepScribe Recent Developments
  19. 7.4 Heidi Health
  20. 7.4.1 Heidi Health Company Information
  21. 7.4.2 Heidi Health Business Overview
  22. 7.4.3 Heidi Health AI-Based Medical Transcription Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Heidi Health AI-Based Medical Transcription Product Portfolio
  24. 7.4.5 Heidi Health Recent Developments
  25. 7.5 InfraWare
  26. 7.5.1 InfraWare Company Information
  27. 7.5.2 InfraWare Business Overview
  28. 7.5.3 InfraWare AI-Based Medical Transcription Revenue and Gross Margin (2021-2026)
  29. 7.5.4 InfraWare AI-Based Medical Transcription Product Portfolio
  30. 7.5.5 InfraWare Recent Developments
  31. 7.6 Rev
  32. 7.6.1 Rev Company Information
  33. 7.6.2 Rev Business Overview
  34. 7.6.3 Rev AI-Based Medical Transcription Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Rev AI-Based Medical Transcription Product Portfolio
  36. 7.6.5 Rev Recent Developments
  37. 7.7 Suki AI
  38. 7.7.1 Suki AI Company Information
  39. 7.7.2 Suki AI Business Overview
  40. 7.7.3 Suki AI AI-Based Medical Transcription Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Suki AI AI-Based Medical Transcription Product Portfolio
  42. 7.7.5 Suki AI Recent Developments
  43. 7.8 Otter.ai
  44. 7.8.1 Otter.ai Company Information
  45. 7.8.2 Otter.ai Business Overview
  46. 7.8.3 Otter.ai AI-Based Medical Transcription Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Otter.ai AI-Based Medical Transcription Product Portfolio
  48. 7.8.5 Otter.ai Recent Developments
  49. 7.9 Verbit.ai
  50. 7.9.1 Verbit.ai Company Information
  51. 7.9.2 Verbit.ai Business Overview
  52. 7.9.3 Verbit.ai AI-Based Medical Transcription Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Verbit.ai AI-Based Medical Transcription Product Portfolio
  54. 7.9.5 Verbit.ai Recent Developments
  55. 7.10 Freed
  56. 7.10.1 Freed Company Information
  57. 7.10.2 Freed Business Overview
  58. 7.10.3 Freed AI-Based Medical Transcription Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Freed AI-Based Medical Transcription Product Portfolio
  60. 7.10.5 Freed Recent Developments
8 North America
  1. 8.1 North America AI-Based Medical Transcription Revenue (2021-2032)
  2. 8.2 North America AI-Based Medical Transcription Revenue by Type (2021-2032)
  3. 8.2.1 North America AI-Based Medical Transcription Revenue by Type (2021-2026)
  4. 8.2.2 North America AI-Based Medical Transcription Revenue by Type (2027-2032)
  5. 8.3 North America AI-Based Medical Transcription Revenue Share by Type (2021-2032)
  6. 8.4 North America AI-Based Medical Transcription Revenue by Application (2021-2032)
  7. 8.4.1 North America AI-Based Medical Transcription Revenue by Application (2021-2026)
  8. 8.4.2 North America AI-Based Medical Transcription Revenue by Application (2027-2032)
  9. 8.5 North America AI-Based Medical Transcription Revenue Share by Application (2021-2032)
  10. 8.6 North America AI-Based Medical Transcription Revenue by Country
  11. 8.6.1 North America AI-Based Medical Transcription Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America AI-Based Medical Transcription Revenue by Country (2021-2026)
  13. 8.6.3 North America AI-Based Medical Transcription Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe AI-Based Medical Transcription Revenue (2021-2032)
  2. 9.2 Europe AI-Based Medical Transcription Revenue by Type (2021-2032)
  3. 9.2.1 Europe AI-Based Medical Transcription Revenue by Type (2021-2026)
  4. 9.2.2 Europe AI-Based Medical Transcription Revenue by Type (2027-2032)
  5. 9.3 Europe AI-Based Medical Transcription Revenue Share by Type (2021-2032)
  6. 9.4 Europe AI-Based Medical Transcription Revenue by Application (2021-2032)
  7. 9.4.1 Europe AI-Based Medical Transcription Revenue by Application (2021-2026)
  8. 9.4.2 Europe AI-Based Medical Transcription Revenue by Application (2027-2032)
  9. 9.5 Europe AI-Based Medical Transcription Revenue Share by Application (2021-2032)
  10. 9.6 Europe AI-Based Medical Transcription Revenue by Country
  11. 9.6.1 Europe AI-Based Medical Transcription Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe AI-Based Medical Transcription Revenue by Country (2021-2026)
  13. 9.6.3 Europe AI-Based Medical Transcription Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China AI-Based Medical Transcription Revenue (2021-2032)
  2. 10.2 China AI-Based Medical Transcription Revenue by Type (2021-2032)
  3. 10.2.1 China AI-Based Medical Transcription Revenue by Type (2021-2026)
  4. 10.2.2 China AI-Based Medical Transcription Revenue by Type (2027-2032)
  5. 10.3 China AI-Based Medical Transcription Revenue Share by Type (2021-2032)
  6. 10.4 China AI-Based Medical Transcription Revenue by Application (2021-2032)
  7. 10.4.1 China AI-Based Medical Transcription Revenue by Application (2021-2026)
  8. 10.4.2 China AI-Based Medical Transcription Revenue by Application (2027-2032)
  9. 10.5 China AI-Based Medical Transcription Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia AI-Based Medical Transcription Revenue (2021-2032)
  2. 11.2 Asia AI-Based Medical Transcription Revenue by Type (2021-2032)
  3. 11.2.1 Asia AI-Based Medical Transcription Revenue by Type (2021-2026)
  4. 11.2.2 Asia AI-Based Medical Transcription Revenue by Type (2027-2032)
  5. 11.3 Asia AI-Based Medical Transcription Revenue Share by Type (2021-2032)
  6. 11.4 Asia AI-Based Medical Transcription Revenue by Application (2021-2032)
  7. 11.4.1 Asia AI-Based Medical Transcription Revenue by Application (2021-2026)
  8. 11.4.2 Asia AI-Based Medical Transcription Revenue by Application (2027-2032)
  9. 11.5 Asia AI-Based Medical Transcription Revenue Share by Application (2021-2032)
  10. 11.6 Asia AI-Based Medical Transcription Revenue by Country
  11. 11.6.1 Asia AI-Based Medical Transcription Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia AI-Based Medical Transcription Revenue by Country (2021-2026)
  13. 11.6.3 Asia AI-Based Medical Transcription Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA AI-Based Medical Transcription Revenue (2021-2032)
  2. 12.2 SAMEA AI-Based Medical Transcription Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA AI-Based Medical Transcription Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA AI-Based Medical Transcription Revenue by Type (2027-2032)
  5. 12.3 SAMEA AI-Based Medical Transcription Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA AI-Based Medical Transcription Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA AI-Based Medical Transcription Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA AI-Based Medical Transcription Revenue by Application (2027-2032)
  9. 12.5 SAMEA AI-Based Medical Transcription Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA AI-Based Medical Transcription Revenue by Country
  11. 12.6.1 SAMEA AI-Based Medical Transcription Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA AI-Based Medical Transcription Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA AI-Based Medical Transcription Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst